ACC.21 Congress (American College of Cardiology 2021 Congress) (Videos)

[

*American College of Cardiology 2021 Congress*
ACC.21, the All Virtual Experience, will feature late-breaking clinical research and education across 11 learning pathways in an engaging and interactive forum providing the latest practice-changing updates in care.
From May 15 – 17, ACC.21 streamed to thousands of members of the cardiovascular team from around the world! Take time to explore ALL the education from ACC.21 with On Demand access. Watch 300+ sessions featuring practice-changing research and cutting-edge education. Plus, don’t miss the more than 3,3000 eAbstracts, 100+ exhibitors, and the opportunity to celebrate the achievements of our colleagues with Convocation. Sample from an unparalleled array of education when it’s convenient for you — from your home, office, or on-the-go — across 11 learning pathways. ACC.21 will leave you up to date on the newest clinical research and you’ll find out how it all impacts the care of your patients.
 

*Contents: (297 videos)

|   406 Joint American College of CardiologyJournal of the American Medical Association Late-Breaking Clinical Trials.ts
|   407 Joint American College of CardiologyNew England Journal of Medicine Late-Breaking Clinical Trials.ts
|   411 Late-Breaking Clinical Trials V.ts
|   908 Highlighted Original Research Multimodality Imaging and the Year in Review.ts
|   910 Highlighted Original Research Ischemic Heart Disease and the Year in Review.ts
|   A Contemporary Understanding of the Diagnosis and Management of Low Flow Low Gradient Severe Aortic Stenosis.ts
|   A Melting Pot of Clinical Valvular Heart Disease Cases No Cookbook, but a Practical Applications from the Valve Guidelines.ts
|   A Practical Approach to Shared Decision Making when Treating Heart Valve Disease.ts
|   A Review of the RADIANCE-HTN Global Clinical Trial Program A Focus on the TRIO cohort.ts
|   ACC Cardiology Hour.ts
|   ACC.21 Highlights in Hypertension.ts
|   ACC21-Frequently-Asked-Questions-UPLOADED-May-11-2021.pdf
|   Acing the Transition What FITs Need to Know to Launch a Healthy, Successful Career.ts
|   Adult Congenital Heart Disease Cases That Stumped Me.ts
|   Advanced Nuclear Cardiology Applications in 2021.ts
|   Advances and new studies for the treatment of MR with Abbott’s TMV repair and replacement therapies.ts
|   Advancing Patient Care Across the Heart Failure Continuum.ts
|   Advancing Systems of Care in STEMI, Stroke, Cardiac Arrest, Shock.ts
|   Anticoagulation Trivia from A to V Management Strategies Across the Board Meeting on Demand.mp4
|   Antithrombotic Controversies in the Cath Lab.ts
|   Antithrombotic Management in Patients with Atrial Fibrillation Undergoing PCI.ts
|   Aortic Valve Interventions Clinical Dilemmas.ts
|   Aortic Valve Interventions Expanding Indications.ts
|   Application of Dual Source CT in cardiac imaging – a focus on Structural Heart Disease.ts
|   Applying the Guidelines For Lipid Management in Special Populations.ts
|   Arrhythmogenic Cardiomyopathies Tell Me What I Need to Know.ts
|   ASCVD Risk Factors and Beyond.ts
|   Atrial Fibrillation Management in Athletes.ts
|   Best of JACC Journals & Eugene Braunwald Keynote.ts
|   Best Practices of Multimodality Imaging in Percutaneous Mitral Interventions.ts
|   Beyond a Broken Heart Multisystem Disease Burden in hATTR Amyloidosis.ts
|   Beyond Atrial Fibrillation – Atrial Cardiopathy as a Cause of Cryptogenic Stroke.ts
|   Bleeding Reduction Strategies Following PCI.ts
|   Breakthrough Transcatheter Pulmonary Valve Treatment Option for Adult and Pediatric CHD Patients.ts
|   Cardiac CT in Clinical Practice.ts
|   Cardiac Culture Medium Current Concepts in Infective Endocarditis.ts
|   Cardiac Imaging in Older Adults Overused or Underutilized Practical Points for Clinicians.ts
|   Cardiac Point of Care Ultrasound Around the World.ts
|   Cardiac Rehab Move to Improve.ts
|   Cardio-Oncology Today’s Standard of Practice.ts
|   Cardiogenic Shock Progress, Paradigms and Unresolved Problems.ts
|   Cardiogenic Shock Teams and Devices for Cardiogenic Shock.ts
|   Cardiologist Versus Calcium Unstoppable Force Meets Immovable Object.ts
|   Cardiovascular Considerations in Amateur and Professional Athletes.ts
|   Cardiovascular Imaging For Diagnosis And Management of Coronary Microvascular Disease.ts
|   Cardiovascular Imaging to Enhance Prevention.ts
|   Caring for the Patient with STEMI in 2021.ts
|   Case Based Learning for the Cardiovascular Team.ts
|   Cases from the Guidelines for Clinicians.ts
|   CCM® Therapy – A Device Based Approach for the Treatment of Heart Failure.ts
|   Challenges of Transplantation in Congenital Heart Disease Patients Ethics, Listing Strategy & MCS.ts
|   Challenging Cases in Cardio-Oncology.ts
|   Chest Pain Evaluation in 2021 Same Problem, New Tools, New Questions.ts
|   Clarity From Confusion in Heart Failure With Preserved Ejection Fraction (HFpEF).ts
|   Clinical Trials Research Upping Your Game.ts
|   Clinical Trials ThunderDome Who Will Be Crowned Most Impactful.ts
|   Complex and High-Risk PCI Case Based Joint Symposium.ts
|   Complex Case-Based Decision-Making – The Heart Team in Action A Joint Symposium by TCT.ts
|   Complex Dilemmas in Valvular Heart Disease.ts
|   Contemporary Aortic Valve Disease Management.ts
|   Contemporary Challenges in Cardiac Critical Care Structure, Staffing, Training and Beyond.ts
|   Controversial Topics in Cardiac Transplantation and Ventricular Assist Devices.ts
|   Controversies in Arrhythmia Therapy.ts
|   Controversies in Interventional and Surgical Management of Congenital Heart Disease.ts
|   Controversies in the ICU Management of Congenital Heart Disease.ts
|   Core Knowledge in Action Essentials of Stable Ischemic Heart Disease.ts
|   Core Knowledge in Action Return to the Basics of Aortic Stenosis.ts
|   Core Knowledge in Action The Ultimate Guide to Lipids.ts
|   Core Knowledge in Action What Everyone Ought To Know About HFpEF.ts
|   Coronary Artery Disease – Atherogenesis, Acute Coronary Syndromes and Stroke.ts
|   Coronary IVL’s Who, What, Where, When & Why An Introductory Guide for Clinical Practice.ts
|   COVID 19 and Heart Failure Lessons Learned and Future Directions.ts
|   COVID-19 and Echocardiography – Impact, Imaging, and Innovation.ts
|   Critical Clinical Conundrums in Acute Coronary Syndromes.ts
|   Current Approaches to Antiplatelet Therapy for PCI in Acute Coronary Syndrome.ts
|   Current Controversies And Debates in CAD Imaging.ts
|   CVD Prevention in the Post-COVID19 Era2.ts
|   Debates in Arrhythmia Management in Congenital Heart Disease.ts
|   Debates Should We Tailor Antiplatelet Therapy for PCI.ts
|   Debating Controversies in STEMI Care.ts
|   Deep Dive I.ts
|   Deep Dive II.ts
|   Destined to Fail How to Prevent Heart Failure.ts
|   Diabesity A Tale of Obesity, Inflammation and Cardiometabolic Risk.ts
|   Diabetes and Heart Failure.ts
|   Diagnostic Testing in Stable Ischemic Heart Disease Choosing Wisely.ts
|   Disparities and the Role of Social Determinants of Health in Acute and Stable Ischemic Heart Disease.ts
|   Dissecting the Data Discussions on the Management of SCAD.ts
|   Doorways To The Heart Valves In Systemic Disease.ts
|   Drug Jeopardy Pharmacological Conundrums in Arrhythmia Management.ts
|   ECGs With the Experts Practical Considerations For the Cardiovascular Clinician.ts
|   Electrical Disorders – Rhythm and Conduction Disorders.ts
|   Emerging Technologies in Vascular Disease.ts
|   Endovascular Skills Basics to Bailout Techniques.ts
|   EP Issues in Cancer Patients – Beyond Heart Failure.ts
|   Essential Vascular Pearls for the Cardiovascular Clinician.ts
|   Essentials of Atrial Fibrillation Management – Learn From the Experts.ts
|   Evolution of Aortic Valve Replacement in Low-Risk Patients.ts
|   Expanding Frontiers in Vascular Intervention.ts
|   Expanding the Toolkit Tackling Residual Atherogenic Lipid Risk.ts
|   Exploring New Synergies Integrating a Cardiac CT Scanner and Interventional C-arm in our Cath Lab.ts
|   Featured Clinical Research I.ts
|   Featured Clinical Research II.ts
|   Featured Clinical Research III.ts
|   Fellows Bootcamp Coronary and Peripheral Disease Management – The Best Cases You Have Seen Yet.ts
|   Fellows Bootcamp Structural.ts
|   FIT Forum Stump the Professor.ts
|   FIT Jeopardy Battle of the State Chapters Finals.ts
|   Focus on Interventional Complications.ts
|   Four Models of Myocardial Disease & Heart Failure – Myocarditis, HFrEF, HFpEF, HCM.ts
|   From Controversy to Clarity in Weight Loss Therapies.ts
|   Fusion imaging for transcatheter edge-to-edge mitral valve repair.ts
|   Gender-Specific Care of Patients with Acute Coronary Syndrome.ts
|   Genetics through Geriatrics – CV Prevention Through the Lifespan.ts
|   Getting to the Root of Dietary Effects.ts
|   Getting Your Life-and-Style Back in CVD.ts
|   Global Burden of Cardiovascular Disease in Women.ts
|   Global Leadership and Professional Education in the COVID-19 Era.ts
|   Great Debates in Vascular Medicine.ts
|   Harnessing the Power of Technology Remote Monitoring and Management in HF.ts
|   Help LDL.ts
|   Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI (2).ts
|   Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI.ts
|   Hemodynamics of Heart Failure You Thought You Knew Them.ts
|   Heterotaxy Syndrome or Somerism Whose Side Are You On.ts
|   Highlighted Original Research Electrophysiology and the Year in Review.ts
|   Highlighted Original Research Heart Failure and Cardiomyopathies and the Year in Review.ts
|   Highlighted Original Research Interventional and Structural and the Year in Review.ts
|   Highlighted Original Research Pediatric and Congenital Heart Disease and the Year in Review.ts
|   Highlighted Original Research Prevention and Health Promotion and the Year in Review.ts
|   Highlighted Original Research Pulmonary Vascular Disease and the Year in Review.ts
|   Highlighted Original Research Valvular Heart Disease and the Year in Review.ts
|   Highlighted Original Research Vascular Medicine and the Year in Review.ts
|   Holy Estrogen! Sex Disparities in Heart Failure Therapies Biology, Bias or Both.ts
|   How Can I Tell If This Aortic Valve Replacement Is Functioning Normally.ts
|   How does Paradise Renal Denervation Fit Into Hypertension Treatment Management.ts
|   How Much is Too Much Navigating Medication Overload by Medication Deprescribing.ts
|   How to be an Effective Mentor & Mentee.ts
|   How to Become a Successful Researcher at Every Stage of Your Career.ts
|   How to Choose and Optimize Pacing in Patients with Heart Failure Conduction System Pacing and CRT.ts
|   How to Deal With Cases That Go From No Problem to Nightmare.ts
|   How to Stent a LM Like a Boss Left Main PCI Workshop.ts
|   Hypertension Guidelines Do They Vary Across the World as Much as My Blood Pressure Has Today .ts
|   Hypertension Management A Future Full of Promises.ts
|   I Know the Evidence So How Do I Incorporate Nutrition and Lifestyle in My Clinic.ts
|   Imagination is Everything Innovations in the Cath Lab.ts
|   Imaging Cardiomyopathies Challenging Cases.ts
|   Imaging Decision Making in Everyday Clinical Practice for Coronary Artery Disease.ts
|   Imaging of Congenital Heart Disease Seeing Things We Never Saw Before.ts
|   Implementing Rhythm Control Guidelines in Atrial Fibrillation The Good, The Bad, and The Ugly.ts
|   Indirect Valvular Heart Disease Problems and Perspectives.ts
|   Innovative Nutritional and Dietary Approaches for Cardiometabolic Disease.ts
|   Insight of BAV Disease from Asia and Western Perspectives.ts
|   International Centers of Excellence Todays Solutions for an Improved Tomorrow.ts
|   Interventional Challenging Cases II An Interventional & SHD Potpourri Not to Miss.ts
|   Interventional Challenging Cases Will Make You Think.ts
|   Invasive Imaging and Physiology Diagnosis and Management of ACS Patients and Plaques.ts
|   Is the Quality of Cardiovascular Research Declining What Research Should Continue to be Pursued.ts
|   Jardiance® (empagliflozin) tablets The Impact of EMPA-REG OUTCOME.ts
|   Jeopardy.ts
|   Journey of the Right Ventricle in Pulmonary Hypertension.ts
|   Kick Starting Your Research Career.ts
|   Late-Breaking Clinical Trials IV.ts
|   Late-Breaking Clinical Trials.ts
|   Launching a Successful Career in Academic Cardiology Key Points to Success.ts
|   Left Atrial Appendage Occlusion Clinical Challenges.ts
|   Left Ventricular Ejection Fraction Past, Present, and Future Role in Heart Failure Care.ts
|   Let’s Get Physical! Exercise and Cardiovascular Health.ts
|   Lifelong Impact of Cardiovascular Risk Factors in Patients with Congenital Heart Disease.ts
|   Living in 3D.ts
|   Lower Extremity PAD Diagnostic Dilemmas, Disparities, and Patient Centered Outcomes.ts
|   Management of Pediatric Cardiology and Cardiac Surgery in the Post-COVID World.ts
|   Managing the Device Patient in 2021 From Cybersecurity, to MRI and Beyond.ts
|   Managing Today’s Advanced Heart Failure Patient.ts
|   Men Are From Mars, Women Are From Venus Sex-Specific Risk Factors That Enhance CVD Risk.ts
|   Minimally Invasive Therapies and Devices in AHF Featuring the 2021.ts
|   MINOCA A Show and Tell With the Experts.ts
|   Mitral Valve Disease and Cardiac Arrest Innocent Bystander or Guilty As Charged.ts
|   Mitral Valve Interventions Percutaneous Mitral Valve Repair.ts
|   Mobile ECG Monitoring How Can We Utilize Wearable Data.ts
|   Multimodality Cardiac Imaging and Modern Media.ts
|   Multimodality Imaging in Cardio-Oncology.ts
|   Multimodality Imaging in Challenging Cases of Infective Endocarditis.ts
|   Multimodality Imaging of Athletes What Do The New Consensus Statement Teach Us.ts
|   Must Know Tips for Publishing in JACC Journals.ts
|   Myocarditis and Heart Failure.ts
|   New AHAACC Valve Guidelines A Paradigm Shift in Management of Severe Aortic Stenosis.ts
|   New and Emerging Breakthrough Medicines for HFrEF! Now What Do We Do.ts
|   New Hypertension Therapies in Asian People.ts
|   New Innovations in Cardiovascular Imaging Incorporating Artificial Intelligence Into Daily Practice.ts
|   New Recommendations on How to Monitor Patients Post TAVRSAVR.ts
|   Nuts & Bolts of Pregnancy and Congenital Heart Disease.ts
|   Obstructive Sleep Apnea and Cardiovascular Outcomes What do Cardiologists Need to Know.ts
|   Off-Beat Topics in Heart Failure Improving Dysfunction By Treating the Rhythm.ts
|   Optimizing LDL-C Management in Recent MI Patients A Focus on Multidisciplinary Care Team Approach.ts
|   Optimizing the Patient Care Pathway and LDL-C Management in Patients with Recent MI.ts
|   Overcoming Therapeutic Inertia Maximizing Guideline Driven Medical Therapy in Heart Failure.ts
|   Parenteral Antithrombotic Therapies for ACS and PCI.ts
|   PCI in patients with CKD Insights from a nephrology and interventional cardiology partnership.ts
|   Perlas practicas en manejo de lipidos.ts
|   Perspectives on Pulmonary Hypertension.ts
|   Pharmacologic and Lifestyle Management for ISHD Why Disparities in Care Matter.ts
|   Pharmacology I Expanding the Cardiovascular Pharmacology Toolbox.ts
|   Pharmacology II Tackling the Supersized Epidemic of Cardio-diabetes.ts
|   Pharmacology III An Ounce of Prevention is Worth a Pound of Cure – Advances in Cardio-Oncology.ts
|   Pharmacotherapy Considerations in Cardio-Obstetrics.ts
|   Polite Parlays in Pulmonary Hypertension.ts
|   Potential Mechanisms Responsible for the Effects of Incretins on Atherosclerosis.ts
|   Practical Pearls on ASCVD and Lipid Management.ts
|   Pre-operative Care for Non-Cardiac Surgery Emerging Strategies and Ongoing Controversies.ts
|   Precision in Classification and Treatment of Heart Failure One Size Does Not Fit All.ts
|   Precision PCI in the Real World What Do I Use Every Day.ts
|   Proarrhythmia Look Outs! From the ICU to the Food We Eat.ts
|   Professional Advancement Across the Academic Cardiology Life Course.ts
|   Professionalism and Ethics in Cardiology.ts
|   Progression of Pulmonary Arterial Hypertension Pharmacotherapy Plainly Played-out in a Patient Case.ts
|   Protected PCI Diagnosis and Treatment of High-Risk and Complex Coronary Disease for Superior Long-term Outcomes.ts
|   Pulmonary Hypertension Primer WHO Are the Groups.ts
|   Raising the Clinical Suspicion for Hypertrophic Cardiomyopathy.ts
|   Rapid Fire Session on Valvular Heart Disease.ts
|   Re-imagining the 90-Day High-Risk Period Post-AMI Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization.ts
|   Recent Trials in SIHD Translating Results into Clinical Practice.ts
|   Registries in Cardiac Imaging How Will they Change Clinical Practice.ts
|   Repair Is Not Correction Long Term Follow-up of Surgery for Congenital Heart Disease.ts
|   Return To Play What The Experts Would Do.ts
|   Reversible Cardiomyopathies Arrhythmias, Pacing, Dyssynchrony and Inflammation.ts
|   Right Sided Valve Interventions.ts
|   Role of Multimodality Imaging in Diagnosis and Management of Cardiovascular Complications in Patients with COVID-19.ts
|   Sex Differences in Arrhythmias.ts
|   Shock Teams and Shock Docs.ts
|   So You Want To Be a Chief of Cardiology.ts
|   Star Wars What Does the Future Hold for EP.ts
|   Sticky Situations for Revascularization in SIHD When the Evidence Is Limited but Opinions Are Vast.ts
|   Strategies for Bleeding Avoidance After Complex PCI.ts
|   Streamlining diagnosis and treatment in chronic coronary artery disease.ts
|   Stress Echo Beyond Obstructive CAD.ts
|   Stroke Prophylaxis Treating the Untreated.ts
|   Structural Complications & How to Deal with Them.ts
|   Structural Heart Disease Challenges in 2021 – Aortic, Mitral and Tricuspid Diseases, Hypertrophic Cardiomyopathies.ts
|   Tackling Cardiometabolic Risk A Case Based Discussion.ts
|   The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and How DISCUSSION.ts
|   The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and HowDIAPOSITIVAS.ts
|   The Constant Debate TAVR Versus SAVR – One Size Does Not Fit All.ts
|   The European Heart Journal’s Year in Cardiovascular Medicine.ts
|   The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 1.mp4
|   The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 2.mp4
|   The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 4.mp4
|   The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 5.mp4
|   The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand3.mp4
|   The Future of Dyslipidemia Management.ts
|   The TeleHealth Cardiac Team Challenges and Opportunities.ts
|   The Time Has Come For Systematic Screening For Asymptomatic Atrial Fibrillation.ts
|   The US-China Consensus on High Efficiency PVI Using RF Energy in Patients with Paroxysmal AF and AF Workflow Sharing.ts
|   Thrombosis & Prevention in COVID-19 What Are We Missing.ts
|   To Right a Wrong in Heart Failure.ts
|   Top Indications for Cardiovascular Magnetic Resonance in Modern Cardiology.ts
|   Topical Topics in Pulmonary Arterial Hypertension.ts
|   Tough Choices Cases in Cardiogenic Shock.ts
|   Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 1.mp4
|   Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 2.mp4
|   Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 3.mp4
|   Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 4.mp4
|   Transcatheter Mitral Valve Replacement Expanding Indications and Trial Update.ts
|   Translational Cardiac Anatomy.ts
|   Treat the Pump or Treat the Rhythm Let’s Talk About Both.ts
|   Treating Comorbidities to Treat Heart Failure Sleep, Exercise, Weight Loss, Iron and More.ts
|   Tricuspid Regurgitation No Longer The Forgotten Valve.ts
|   Under the Bright Light Debates in Interventional Cardiology.ts
|   Understanding the Impact of Lp(a) in ASCVD A focus on added CV risk, guidelines, and testing.ts
|   Unfolding the Mysteries of Cardiac Amyloidosis.ts
|   Uniquely Bicuspid Valve Two Leaflets and A Tool Kit.ts
|   Universal Definition of Heart Failure.ts
|   Updates in Management of Hypertrophic Cardiomyopathy.ts
|   Use of Direct Oral Anticoagulants in Special Populations Complex Dosing Strategies and Complicated Patients.ts
|   Valvular Conundrums Grey Area Cases, What the Experts Think.ts
|   VASCEPA® (icosapent ethyl) Elevating the Standard of Care.ts
|   Vascular Manifestations of COVID-19 Around the Globe.ts
|   Vasculo-Oncology Lessons Learned for Clinical Practice in 2021.ts
|   Venous Interventions 2021.ts
|   Venous Thromboembolism Current Controversies and Practical Management.ts
|   Virtual Outpatient Experience for Cardiac Electrophysiologists High Yield Topics.ts
|   Vulnerable Plaques Intervention or Pharmacologic Therapy.ts
|   Watchman Transmission.ts
|   What Can We Learn From Each Other For Global Heart Failure Care.ts
|   What You Don’t Know Can’t Help Them – Remote Management of Patients Using Wearables.ts
|   What’s In a Name Practicalities of the 4th Universal Definition of MI.ts
|   What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 1.mp4
|   What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 2.mp4
|   What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 3.mp4
|   What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 4.mp4
|   What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 5.mp4
|   When Fat Overpowers Muscle Obesity and the HFpEF Epidemic.ts
|   Working Together to Improve Pediatric and Congenital Heart Disease Care Around the World 5.ts
|   World Heart Federation Featured Research With Year in Review.ts
|   Yes, No, Maybe How to Diagnose and Treat INOCA (Ischemia and No Obstructive Coronary Artery Disease) Today.ts
|   Your PVI Toolkit.ts

Reviews
There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

]